MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $40,000 | -97.7% | 4,694 | -96.6% | 0.00% | -100.0% |
Q2 2015 | $1,710,000 | -4.0% | 138,297 | -7.8% | 0.00% | 0.0% |
Q1 2015 | $1,782,000 | -29.6% | 150,049 | -34.2% | 0.00% | -25.0% |
Q4 2014 | $2,530,000 | +46.6% | 228,103 | +16.0% | 0.00% | +33.3% |
Q3 2014 | $1,726,000 | +150.9% | 196,622 | +69.0% | 0.00% | +200.0% |
Q2 2014 | $688,000 | +34300.0% | 116,322 | +23883.9% | 0.00% | – |
Q3 2013 | $2,000 | +100.0% | 485 | +385.0% | 0.00% | – |
Q2 2013 | $1,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 1,560,530 | $17,634,000 | 4.71% |
B & T Capital Management DBA Alpha Capital Management | 280,113 | $3,165,000 | 2.22% |
Schonfeld Group Holdings LLC | 10,000 | $113,000 | 1.51% |
COLUMBIA CAPITAL LLC | 117,702 | $1,331,000 | 1.45% |
Portolan Capital Management | 607,288 | $6,862,000 | 1.38% |
Price Capital Management, Inc. | 118,047 | $1,334,000 | 1.18% |
GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,025,000 | 0.93% |
Opus Point Partners Management, LLC | 72,009 | $814,000 | 0.80% |
EAM Investors, LLC | 412,233 | $4,658,000 | 0.65% |
TFS CAPITAL LLC | 476,105 | $5,380,000 | 0.51% |